CCL5 and breast cancer: Regulated on activation, normal T cell expressed and secreted (RANTES), also known as CCL5 and functioning on receptor CCR5, is a cytokine that continues to increase in breast cancer subtypes (63) and is associated with promoting breast cancer metastasis and progression (64, 65).